William Brumskine, MBChB, Dip HIV Man (SA)

William
Brumskine
MBChB, Dip HIV Man(SA)
Clinical Research Site Leader
The Aurum Institute NPC - Rustenburg CRS
Adjunct Instructor
Department of Infectious Disease, Vanderbilt University School of Medicine
wbrumskine@auruminstitute.org

Global Health Research Interests: Clinical Trials, COVID, HIV/AIDS, Infectious Diseases, Tuberculosis (TB)

Country: South Africa

Experienced clinical research physician with a demonstrated history of working in the research industry. Skilled in clinical practice, reproductive health, pharmacovigilance, healthccare, and clinical research. Strong infectious disease interest with a Dip HIV Man (SA) degree focused on HIV management in a scarce resource setting from College of Family Physicians of South Africa.

The Aurum Institute
Parktown, South Africa

Michael C. Dewan, MD, MSCI

Michael
C.
Dewan
MD, MSCI
Associate Vice Chair of Global Surgery, Vanderbilt University Medical Center
Assistant Professor Department of Neurological Surgery
Assistant Professor Department of Pediatrics, Hematology & Oncology
Academic Director
Global Neurosurgery Program
Surgical Director
Pediatric Neuro-Oncology Program
Surgical Director
Pediatric Neuro-Vascular Program

MD_surgeryMichael Dewan MD, MSCI is an Assistant Professor in the Department of Neurological Surgery, Division of Pediatric Neurosurgery at the Monroe Carell Jr. Children’s Hospital at Vanderbilt (MCJCHV) and the Vanderbilt University Medical Center (VUMC). He is the Surgical Director of the Pediatric Neuro-Oncology Program, the Pediatric Neuro-Vascular Program, and the Academic Director of the Global Neurosurgery Program.

In 2016, he co-founded the Global Neurosurgery Initiative within the Global Surgery and Social Change Program at Harvard Medical School, now a leading center for international neurosurgical collaboration, advocacy, and scientific progress. He has developed surgical educational modules for neurosurgeons in low- and middle-income countries (LMICs), which are now being used in more than a dozen countries in Asia and Sub-Saharan Africa. His expertise in treating childhood brain tumors and neurovascular disorders has informed ongoing and completed multicenter clinical studies. His extensive experience in the endoscopic management of hydrocephalus and the treatment of congenital neurologic defects and his development of a research platform to improve outcomes have fueled an international consortium of centers addressing these conditions in LMICs.

Dr. Dewan maintains active research and capacity-building collaborations with partners in more than a dozen countries throughout Sub-Saharan Africa and Southeast Asia.  He has mentored numerous medical students and residents in funded research initiatives, successfully culminating in publications and trainee advancement. 

Education

BS, University of Notre Dame
MD, Yale Medical School
MSCI, Vanderbilt University

Training

Resident, Neurological Surgery, Vanderbilt University Medical School
Fellow, Global Health and Social Medicine, Harvard Medical School
Chief Fellow, Pediatric Neurosurgery, University of Toronto

 

michael.dewan@vumc.org

Global Health Research Interests: Epidemiology, Neurological Surgery

Countries: Australia, Brazil, Canada, Croatia, Egypt, Ethiopia, Ghana, Israel, Japan, Jordan, Kenya, Nigeria, Pakistan, Philippines (the), South Africa, Spain, Switzerland, Tanzania, United Republic of, Zambia

Dewan

Prevention of Stroke in Children with Sickle Cell Anemia in Nigeria: A task shifting community hospital approach

Stroke is a devastating complication of sickle cell anemia (SCA) occurring in approximately 11% of children affected with the disease in resource-limited countries, compared to 1% in high-income countries. Nigeria bears 50% of childhood SCA's global burden, and stroke is a frequent complication leading to increased death and disability.

Moderate fixed‐dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: Final results of the SPIN trial

Sickle cell disease (SCD), an inherited blood disorder, is prevalent throughout sub-Saharan Africa. Approximately 240,000 children are born with SCD each year across the continent of Africa, and up to 70% of those infants born with sickle cell disease die before the age of five. 

University students in Nigeria willing to self test for HIV, cross-sectional study

A recent study co-authored by Dr. Muktar Aliyu, M.D., MPH, DrPH, professor of Health Policy and Medicine and associate director for research for VIGH, assessed the willingness of students at Bayero University in Nigeria to self-test for HIV. The World Health Organization (WHO) encourages the use of HIV self-testing, especially in areas such as West and Central Africa where 64% of people living with HIV are unaware of their status.

VIGH awarded $3 million for building research capacity in Nigeria and Mozambique

Vanderbilt Institute for Global Health (VIGH) has received a new research training grant and a renewal for an existing training program from the Fogarty International Center (FIC) of the National Institutes of Health (NIH) to build HIV-focused research capacity with key partners in Nigeria and Mozambique. One of the $1.5 million grants will establish The Vanderbilt-Nigeria Building Research Capacity in HIV/Non-communicable Diseases (V-BRCH) Program to build capacity of Nigerian investigators to successfully initiate and implement high-quality clinical trials in HIV-associated non-communicable diseases.

Vanderbilt-Nigeria Building Research Capacity in HIV/Non-communicable Diseases (V-BRCH)

The Vanderbilt-Nigeria Building Research Capacity in HIV/Non-communicable Diseases (V-BRCH) Program builds capacity of Nigerian investigators to successfully initiate and implement high-quality clinical trials in HIV-associated non-communicable diseases.

2020 Global Health Graduates

This year, 11 students graduated with a Master of Public Health (MPH) in Global Health, and seven received the Graduate Certificate in Global Health. Although official in-person Vanderbilt University graduations have been postponed to May 2021, the MPH Program held a virtual celebration for graduates and their families, friends, and mentors on May 8. The celebration included heartwarming presentations from students about their experiences in the Program and celebrated students who received awards. Congratulations, graduates!

Vanderbilt Lab Donation Supports Medical Education in Liberia

At the end of March, the Vanderbilt Institute for Global Health received a long-awaited message from Liberia – the 40-foot shipping container of medical books and other laboratory equipment donated by the Vanderbilt School of Medicine had survived it’s journey across the ocean and arrived at its final destination, the University of Liberia. The letter signaled the end of a nearly year-long donation effort at Vanderbilt and the beginning of new opportunities for current and future medical students in Liberia.